Delivery Order SPE2DB22D1202-SPE2DB25FVER3
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,060,794 units of the medication Phytonadione 1 mg/0.5 ml syringe, with a ceiling value of $8,647.82. The award has an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, with ID SPE2DB22D2006|SPE2DB25FW0ML, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,408.14 firm fixed-price delivery order is for the supply of Phytonadione 1 mg/0.5 ml syringe, 0.5 ml, with a performance period through May 2, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Phytonadione 5 mg tablets. The $26,184.56 firm-fixed-price contract has an ultimate completion date of August 23, 2022 and was awarded on August 22, 2022. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025, which serves as the...
- This is a federal contract award issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,210,645 units of the drug phytonadione in 0.5 mL doses, with a ceiling value of $8,508.35. The contract is a Firm Fixed Price Delivery Order with a completion date of June 9, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug Corp is the prime...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,453.28 firm fixed-price contract is for the delivery of 4,562,280,800 phytonadione 5 mg tablets, with a completion date of September 25, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,405.51, is for the delivery of Phytonadione 1 mg/0.5 ml syrup in 0.5 ml quantities. The contract has a period of performance through December 27, 2023 and is a firm-fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award is a Delivery Order valued at $2,653.87, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PHYTONADIONE 1 MG/0.5 ML SYR 0.5ML, a pharmaceutical product, with a period of performance through June 11, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 0.5 mL syringes of the medication phytonadione (vitamin K1) with a firm fixed price of $6,851.52. The contract has an ultimate completion date of June 13, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award, with ID SPE2DX15D6028|SPE2DX25FWLED, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $17,532.73 firm-fixed-price delivery order is for the supply of 4568031837 - Phytonadione .5ML 10S, a medical product. This award is not set-aside and is part of AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides comprehensive global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes valued at $2,716.90, with completion targeted for July 21, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVER3Delivery Order
This is a $1,903.20 firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of the drug Phytonadione 1 mg/0.5 ml syringe with a completion date of July 16, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award is not set-aside, indicating open competition. As a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems, Amerisourcebergen has a history of delivering diverse medical products, including prescription medications, medical devices, specialty pharmaceuticals, and other healthcare-related supplies to government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/15/25 |